The tumour microenvironment and immune milieu of cholangiocarcinoma
Luca Fabris(University of Padua), Mario Strazzabosco(Smilow Cancer Hospital), Thorsten Cramer(Universitätsklinikum Aachen), Antonio Solinas(University of Sassari), María J. Perugorria(Ikerbasque), Ana Lleò(Humanitas University), Anja Moncsek(University Hospital of Zurich), Hanna Sänger(Technische Universität Dresden), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Alexander Siebenhüner(University Hospital Zurich), Veronika Lukacs‐Kornek(University Hospital Bonn), Niklas K. Björkström(Karolinska University Hospital)
Cited by 194
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
|Nature Medicine|2016|383